Search results for "231"

showing 5 items of 335 documents

Reescritura de las fuentes y sustituciones léxicas en el De Proprietate Animalium de Manuel Files: ¿variación estilística o cambio de nivel lingüísti…

2020

El De Proprietate Animalium de Manuel Files es un poema didáctico del s. XIV que parafrasea libremente varias fuentes literarias de contenido zoológico, entre las que destaca la Historia Animalium de Claudio Eliano. Un análisis detallado de los procedimientos de sustitución léxica realizado por el autor, apoyado en la consulta de los diccionarios bizantinos, permite reconocer su originalidad compositiva, la riqueza expresiva de su vocabulario poético, pero también la clara conciencia de la existencia de diferentes niveles de lengua y de los muy diversos registros utilizados por el autor.

pero también la clara conciencia de la existencia de diferentes niveles de lengua y de los muy diversos registros utilizados por el autor. 143 175UNESCO::CIENCIAS DE LAS ARTES Y LAS LETRAS1135-9560 8276 Studia philologica valentina 567083 2020 22 7762319 Reescritura de las fuentes y sustituciones léxicas en el De Proprietate Animalium de Manuel Files: ¿variación estilística o cambio de nivel lingüístico? Vives Cuesta:CIENCIAS DE LAS ARTES Y LAS LETRAS [UNESCO]¿variación estilística o cambio de nivel lingüístico? Vives Cuesta [1135-9560 8276 Studia philologica valentina 567083 2020 22 7762319 Reescritura de las fuentes y sustituciones léxicas en el De Proprietate Animalium de Manuel Files]Alfonso El De Proprietate Animalium de Manuel Files es un poema didáctico del s. XIV que parafrasea libremente varias fuentes literarias de contenido zoológicopermite reconocer su originalidad compositivala riqueza expresiva de su vocabulario poéticoentre las que destaca la Historia Animalium de Claudio Eliano. Un análisis detallado de los procedimientos de sustitución léxica realizado por el autorapoyado en la consulta de los diccionarios bizantinos
researchProduct

Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial

2020

Funding: Transgène; International audience; Treatment of chronic hepatitis B (CHB) typically requires life-long administration of drugs. Cohort and pre-clinical studies have established the link between a functional T-cell-mounted immunity and resolution of infection. TG1050 is an adenovirus 5-based vaccine that expresses HBV polymerase and domains of core and surface antigen and has shown immunogenicity and antiviral effects in mice. We performed a phase 1 clinical trial to assess safety and explore immunogenicity and early efficacy of TG1050 in CHB patients. This randomized, double blind, placebo-controlled study included two sequential phases: one single dose cohort (SD, n = 12) and one …

safetyHBsAg030231 tropical medicineImmunologyPlacebo-controlled studyPhases of clinical researchSciences du Vivant [q-bio]/Médecine humaine et pathologieimmunogenicityPlaceboAntiviral AgentsAdenoviridae03 medical and health sciencesMice0302 clinical medicineHepatitis B ChronicImmunogenicity VaccinevaccineImmunology and AllergyMedicineAnimalsHumans030212 general & internal medicineAdverse effectPharmacologyVaccinesHepatitis B Surface Antigens[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologybusiness.industryELISPOTImmunogenicitychronicityimmuno-therapyHepatitis Bmedicine.diseaseHepatitis B3. Good healthImmunologybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyResearch Paper
researchProduct

Euclid preparation: XI. Mean redshift determination from galaxy redshift probabilities for cosmic shear tomography

2021

Ilbert, O., et al. (Euclid Collaboration)

statistical [Methods]IMPACTUNIVERSEAstrophysics01 natural sciencesDark energyGalaxies: distances and redshiftdark energyPHOTOMETRIC REDSHIFTS010303 astronomy & astrophysicsWeak gravitational lensingPhotometric redshiftmedia_commonPhysicsdistances and redshift [Galaxies]Dark energy; Galaxies: distances and redshifts; Methods: statisticalSIMULATIONastro-ph.CO3103 Astronomy and AstrophysicsProbability distributionSpectral energy distributiongalaxies: distances and redshiftsAstrophysics - Cosmology and Nongalactic AstrophysicsCosmology and Nongalactic Astrophysics (astro-ph.CO)530 Physicsastro-ph.GAmedia_common.quotation_subjectFOS: Physical sciencesAstrophysics::Cosmology and Extragalactic Astrophysics1912 Space and Planetary Science0103 physical sciencesdistances and redshifts [Galaxies]/dk/atira/pure/subjectarea/asjc/1900/1912DISTRIBUTIONSmethods: statistical010308 nuclear & particles physicsAstronomy and AstrophysicsPERFORMANCE115 Astronomy Space scienceAstrophysics - Astrophysics of GalaxiesEVOLUTIONGalaxyUniverseRedshiftSTELLARRESOLUTIONSpace and Planetary Science10231 Institute for Computational ScienceAstrophysics of Galaxies (astro-ph.GA)Dark energy/dk/atira/pure/subjectarea/asjc/3100/3103[PHYS.ASTR]Physics [physics]/Astrophysics [astro-ph]
researchProduct

Pressure-Dependent Tuning of Photoluminescence and Size Distribution of Carbon Nanodots for Theranostic Anticancer Applications

2020

Carbon nanodots (CDs) have recently attracted attention in the field of nanomedicine because of the biocompatibility, cost-effective nature, high specific surface, good near infrared (NIR) photothermal conversion into heat and tunable fluorescence properties, which have paved the way toward incorporating use of CDs into innovative anticancer theranostic platforms. However, a reliable synthesis of CDs with established and controlled physiochemical proprieties is precluded owing to the lack of full manipulation of thermodynamic parameters during the synthesis, thus limiting their use in real world medical applications. Herein, we developed a robust solvothermal protocol which allow fine contr…

theranosticsMaterials sciencePhotoluminescenceBiocompatibilityMDA-MB-231Nanotechnology02 engineering and technologySurface engineering010402 general chemistrylcsh:Technology01 natural sciencesArticleFluorescence spectroscopyAdsorptionGeneral Materials Sciencecarbon nanodotsFourier transform infrared spectroscopylcsh:Microscopylcsh:QC120-168.85lcsh:QH201-278.5lcsh:T021001 nanoscience & nanotechnology0104 chemical scienceslcsh:TA1-2040cancer therapyNanomedicineSurface modificationlcsh:Descriptive and experimental mechanicslcsh:Electrical engineering. Electronics. Nuclear engineeringlcsh:Engineering (General). Civil engineering (General)0210 nano-technologylcsh:TK1-9971phototherapyMaterials
researchProduct

ABC saimes gēnu ekspresija un vēža cilmes šūnu fenotipiskās izpausmes pret doksorubicīnu rezistentā MDA-MB-231 apakšpopulācijā

2018

Rezistence pret citotoksiskiem ķīmijterapijas savienojumiem ir nozīmīga problēma vēža ārstēšanā, kam raksturīga audzēja atjaunošanās un slimības progresēšana. Rezistenci pret ķīmijterapijas savienojumiem var veidot dažādi šūnu mehānismi, no kuriem visplašāk aprakstīta ATF saistošās kasetes (ABC) transportproteīnu pārekspresija. Rezistenci visbiežāk veicina pret ķīmijterapijas savienojumiem rezistentu apakšpopulāciju selekcija. Vēža cilmes šūnām (VCŠ) piemīt spēja izvairīties no ķīmijterapijas ietekmes un atjaunot audzēja šūnu populāciju. Darba mērķis bija noteikt ABC saimes gēnu ekspresiju un raksturot VCŠ raksturīgās pazīmes pret doksorubicīnu rezistentā trīskārši negatīva krūts vēža šūnu …

vēža cilmes šūnasMDA-MB-231Bioloģijaķīmijterapijas rezistenceABC saimes gēnidoksorubicīns
researchProduct